Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Shore Capital still sees upside at AB Foods despite recent woes

(Sharecast News) - Shore Capital has kept a 'buy' rating on Associated British Foods despite a "mellow" trading update from the food and retail company last week, saying that it still sees upside following a disappointing run in the shares so far this year. ABF shares dropped last week after the company reported that it was facing a number of challenges, from weaker shopper sentiment in France to oversupplied sugar markets across Europe and a flat performance at its Primark division.

As a result, Shore Capital has cut its EPS estimates for the year to 13 September by 1.8% to 170.4p, implying a 14% year-on-year fall.

The broker has also reduced forecasts for the following year, saying that a recovery in the struggling Sugar division "may be a bit further out than [the company] first thought".

Nevertheless, Shore Capital kept an optimistic view on the shares, saying: "The stock trades on disappointing multiples, reflecting the news flow of 2025, where EPS is forecast to fall by c.14% YoY. However, whilst a poor equity performer this year, the investment programme, financial constitution and prospects for the firm mean we see value and so keep our somewhat bruised BUY stance."

ABF shares were 1% lower at 1,981.5p by 1328 BST, putting it down 13% over the past month alone.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.